dc.contributor.author | Srinivasan, Charudharshini | |
dc.contributor.author | Weight, Alisha Kessel | |
dc.contributor.author | Bussemer, Till | |
dc.contributor.author | Klibanov, Alexander M. | |
dc.date.accessioned | 2016-06-14T19:52:23Z | |
dc.date.available | 2016-06-14T19:52:23Z | |
dc.date.issued | 2013-03 | |
dc.date.submitted | 2012-12 | |
dc.identifier.issn | 0724-8741 | |
dc.identifier.issn | 1573-904X | |
dc.identifier.uri | http://hdl.handle.net/1721.1/103112 | |
dc.description.abstract | Purpose:
The aim of this study was to markedly lower the viscosities of highly concentrated protein, in particular antibody, formulations. An effective approach elaborated herein for γ-globulin and a monoclonal antibody is to replace aqueous solutions with equimolar suspensions in neat organic solvents.
Methods:
Viscosities of aqueous solutions and non-aqueous suspensions of the model protein bovine γ-globulin and a murine monoclonal antibody were examined under a variety of experimental conditions. In addition, protein particle sizes were measured using dynamic light scattering and light microscopy.
Results:
Concentrated suspensions of amorphous γ-globulin powders (up to 300 mg/mL, composed of multi-micron-sized particles) in absolute ethanol and a number of other organic solvents were found to have viscosities up to 38 times lower than the corresponding aqueous solutions. Monoclonal antibody follows the same general trend. Additionally, the higher the protein concentration and lower the temperature, the greater the viscosity benefit of a suspension over a solution.
Conclusions:
The viscosities of concentrated γ-globulin and monoclonal antibody suspensions in organic solvents are drastically reduced compared to the corresponding aqueous solutions; the magnitude of this reduction depends on the solvent, particularly its hydrogen-bonding properties. | en_US |
dc.description.sponsorship | Sanofi Aventis (Firm) | en_US |
dc.description.sponsorship | Massachusetts Institute of Technology. Biophysical Instrumentation Facility (Study of Complex Macromolecular Systems (NSF-0070319)) | en_US |
dc.description.sponsorship | Massachusetts Institute of Technology. Biophysical Instrumentation Facility (Study of Complex Macromolecular Systems (NIH GM68762 instrumentation grant) | en_US |
dc.publisher | Springer Science+Business Media | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1007/s11095-013-1017-4 | en_US |
dc.rights | Creative Commons Attribution-Noncommercial-Share Alike | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | en_US |
dc.source | Springer US | en_US |
dc.title | Non-Aqueous Suspensions of Antibodies are Much Less Viscous Than Equally Concentrated Aqueous Solutions | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Srinivasan, Charudharshini, Alisha K. Weight, Till Bussemer, and Alexander M. Klibanov. “Non-Aqueous Suspensions of Antibodies Are Much Less Viscous Than Equally Concentrated Aqueous Solutions.” Pharmaceutical Research 30, no. 7 (March 30, 2013): 1749–1757. | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biological Engineering | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Chemistry | en_US |
dc.contributor.mitauthor | Srinivasan, Charudharshini | en_US |
dc.contributor.mitauthor | Weight, Alisha Kessel | en_US |
dc.contributor.mitauthor | Klibanov, Alexander M. | en_US |
dc.relation.journal | Pharmaceutical Research | en_US |
dc.eprint.version | Author's final manuscript | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2016-05-23T12:15:10Z | |
dc.language.rfc3066 | en | |
dc.rights.holder | Springer Science+Business Media New York | |
dspace.orderedauthors | Srinivasan, Charudharshini; Weight, Alisha K.; Bussemer, Till; Klibanov, Alexander M. | en_US |
dspace.embargo.terms | N | en |
dc.identifier.orcid | https://orcid.org/0000-0003-3830-714X | |
mit.license | OPEN_ACCESS_POLICY | en_US |